Kutatási jelek – Signal Engine

• Yes-associated protein 1 (YAP1) expression in adenoid cystic carcinoma of the lacrimal gland — Adenoid cystic carcinoma
• Frontiers | The research progress of the synergistic effect of Epstein‑Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer — Gastric cancer
• Identification of plasma lipidomic biomarkers for prognostic stratification in advanced gastric cancer treated with PD-1 inhibitor plus chemotherapy — Gastric cancer
• A Comprehensive Computational Investigation of Novel Hydrazide
  Hydrazone Derivatives as Potential EGFR Inhibitors for Gastric Cancer Treatment — Gastric cancer
• Plant-Derived Diterpenoids as Potential Chemotherapeutics for Gastric Cancer — Gastric cancer
• A population‑based analysis evaluating risk of second primary upper abdominal cancers following radiotherapy for resectable gastric cancer — Gastric cancer
• Optimizing gastric cancer treatment: the role of LODDs in lymph node staging — Cholangiocarcinoma
• Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based study — Esophageal cancer
• Predictive Value of Insertion/Deletion Rate in Patients With Gastric Cancer Treated With Nivolumab Plus Chemotherapy — Gastric cancer
• Baseline IL-6 independently predicts severe immune-related toxicity and poor survival in advanced gastric cancer treated with immunotherapy — Gastric cancer
• Analysis of differences between early-onset and late-onset early gastric cancer treated with endoscopic submucosal dissection — Gastric cancer
• Metabolic syndrome as an independent predictor of response and survival in locally advanced gastric cancer treated with neoadjuvant immunochemotherapy — Esophageal cancer
• EGCG inhibits gastric cancer HGC27 cells invasion and migration by targeting the Hedgehog signaling pathway — Nasopharyngeal carcinoma
• Gastric cancer tertiary lymphoid structures in the muscularis propria are associated with therapy resistance and promote immunosuppression — Gastric cancer
• PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by first-line treatment without immune checkpoint inhibitors: JCOG1013A1 — Gastric cancer
• Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance — Gastric cancer
• Editorial: Innovative pathological approaches for poorly cohesive gastric cancer — Gastric cancer
• Cutting Two Amino Acids Slowed Prostate Cancer in Mice — Prostate cancer
• NIKTIMVO Market Size Analysis and Sales Forecast, 2034 — Cholangiocarcinoma
• Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery — Head and neck squamous cell carcinoma